On December 20, 2019 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) reported will webcast its presentation at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 (Press release, Regeneron, DEC 20, 2019, View Source [SID1234552562]). The presentation is scheduled for 10:30 a.m. Pacific Time (1:30 p.m. Eastern Time) and may be accessed from the "Investors & Media" page of Regeneron’s website at View Source A breakout session will immediately follow the formal presentation and can also be accessed from our website. An archived version of the presentation and the breakout session will be available for at least 30 days.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Following the announcement regarding the Intent to Restructure the Antibody Collaboration for Kevzara (sarilumab) and Praluent (alirocumab) with Sanofi, Regeneron will provide financial guidance for 2020 at a date subsequent to the J.P. Morgan Healthcare Conference.